Clobetasol Propionate
Pricing Report NDC 0781-7137-04

Latest NADAC: $0.60047 per ML · Effective Apr 20, 2022 · Est. package price $70.86 (118 ML)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Clobetasol Propionate (NDC 0781-7137-04) is $0.60047 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 20, 2022.

As a provided by Sandoz Inc., this medication is distributed in a 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.60047
Per ML

Effective Date
Apr 20, 2022
Billable Units
118 ML
Estimated Package Price
$70.86
Data Status
As of Apr 27, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.53083 to $2.44869 per ML. Over this 8 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.5308 - $2.4487
Market Volatility
361.29% Variance
Latest Trend
11.11%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 20, 2022 $0.60047 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 23, 2022 $0.54041 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 23, 2022 $0.54945 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 19, 2022 $0.53083 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 22, 2021 $0.66663 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 17, 2021 $0.76938 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 20, 2021 $0.79027 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 22, 2021 $0.80036 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 18, 2021 $0.76033 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 21, 2021 $0.98551 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 23, 2021 $0.94583 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 19, 2021 $0.97058 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026